Ashton Thomas Securities »

Regeneron Pharmaceuticals shares owned by Ashton Thomas Securities

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ashton Thomas Securities from 13F filings

Historical chart of Ashton Thomas Securities investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Ashton Thomas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Ashton Thomas Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $831k 790 1051.24

More positions owned by Ashton Thomas Securities

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Total Usd (IUSB)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Equal Wegt 0-30 (GOVI)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for Ashton Thomas Securities

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
Invesco
Bank of America Corporation
Amundi
Goldman Sachs Group

View all funds holding Regeneron Pharmaceuticals